Your email has been successfully added to our mailing list.

×
0 0.0023724792408068 -0.00593119810201648 -0.00830367734282307 -0.0142348754448398 -0.013641755634638 -0.0273546856465005 -0.0272835112692762
Stock impact report

Bearish CEL-SCI Article Ignored Scientific Evidence And Misinterpreted Multikine's Clinical Trial Design [Seeking Alpha]

Cel-Sci Corporation (CVM) 
NASDAQ:AMEX Investor Relations: cel-sci.com/investor_relations.html
Company Research Source: Seeking Alpha
Bearish CEL-SCI Article Ignored Scientific Evidence And Misinterpreted Multikine's Clinical Trial Design Summary The mechanism of action for cytokines in helping the immune system respond to malignant growth in the head and neck has been well documented by medical research. New research indicates short-term dosing in immunotherapy leads to a "long tail effect" in significantly improving survival 2-3 years later. Multikine's event-based trial design indicates any delay would imply an increase in survival rates, especially considering the IDMC has not recommended more patient enroll as per drop-out protocol. pCR has been demonstrated to be a poor preliminary indicator for neoadjuvant therapy, as opposed to the trial's primary endpoint of improvement in overall survival rates. Adam Feuerstein's bearish article on CVM lacks basic understanding of statistics and clinical trial design. Introduction: CEL-SCI (NYSEMKT: 1992 $2.0 billion Key Research: Delays in Phase 3 are Positive By Trial De Show less Read more
Impact Snapshot
Event Time:
CVM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
CVM alerts

from News Quantified
Opt-in for
CVM alerts

from News Quantified